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The switch from culture-based enumeration to deep sequencing has enabled microbial community compo-
sition to be profiled en masse. In a new article, Maurice et al. (2013) report the use of fluorescence-activated
cell sorting (FACS) to perform a high-throughput analysis of gut microbiota community function.The big advance that sets the latest
wave of microbiome research apart from
earlier studies is deep sequencing: the
ability to enumerate all of the cells in
a complex microbial community at once.
The switch from a low-throughput tech-
nique, culture-based enumeration, to the
high-throughput technology of deep seq-
uencing enabled the ‘‘magic’’ of viewing
community composition from 30,000
feet (Figure 1). Not surprisingly, many of
the key insights from the last few years
of microbiome research—spatiotemporal
variation in the microbiome (Costello
et al., 2009), the effect of diet on the gut
community (Turnbaugh et al., 2009),
development of the infant microbiome
(Dominguez-Bello et al., 2010; Koenig
et al., 2011; Yatsunenko et al., 2012),
and the response of the gut community
to antibiotic treatment (Dethlefsen and
Relman, 2011)—would have been difficult
to glean from culture-based studies.
There is a great deal yet to learn
about the microbiome from deep
sequencing; many of the key questions
that remain unanswered concern the
temporal dynamics of the microbiota
and disease-specific changes in commu-
nity composition. Nevertheless, a con-
sensus is emerging in the microbiome
research community that questions
about community composition—which
are addressed by deep sequencing—
should be accompanied by new lines of
inquiry into community function (http://
grants.nih.gov/grants/guide/rfa-files/RFA-
RM-12-021.html). Taking microbiome
insights from bench to bedside, the argu-
ment goes, will require a molecular-level
understanding of function: metabolism of
dietary inputs, synthesis of diffusible
molecules and surface antigens, and
modulation of host signaling pathways.
Such a detailed description of host-microbiota interactions would reveal how
the composition and function of the gut
community relate to disease; how they
can be modulated by small molecule
drugs, probiotics, and prebiotics; and
what the goals of those perturbations
should be.
Classically, the study of microbial func-
tion has been a low-throughput endeavor.
Notable papers have explored the biolog-
ical role of a single molecule produced by
an individual microbial species (Mazma-
nian et al., 2005; Shin et al., 2011). An
important exception has been a series of
metabolomic studies of the microbiota
from Nicholson and coworkers, which
have highlighted key microbial metabo-
lites and unexpected similarities and
differences in function among gut micro-
bial communities (Nicholson et al., 2012).
In an exciting new manuscript, Turn-
baugh and colleagues adapt a high-
throughput technique pioneered for the
analysis of aquatic microbial communities
to study the metabolic state of the gut
microbiota en masse (Figure 1) (Maurice
et al., 2013). This technique consists of
treating an intact microbial community
(e.g., a human fecal sample) with the fluo-
rescent dyes SYBR Green, propidium
iodide (Pi), and DiBAC and using fluores-
cence-activated cell sorting (FACS) to
determine the proportion of dye-positive
versus dye-negative cells. SYBR Green
binds to DNA and reports on the total
quantity of DNA in a cell. The level of
SYBR Green fluorescence can therefore
distinguish between cells with high and
low nucleic acid content (HNA and LNA,
respectively); HNA cells are presumed to
be actively dividing and/or to have an
increased metabolic activity, while LNA
cells are not. Propidium iodide is ex-
cluded by cells with an intact membrane,
and DiBAC can enter depolarized cells,Cell Host & Microbe 13,so cells that are Pi+ or DiBAC+ are
presumed ‘‘damaged.’’ The authors used
this FACS-based assay to profile the
metabolic activity of tens of thousands of
cells from each of 21 fecal samples from
three individuals, both fresh and after
treatment with antibiotics or other drugs.
Three of their findings are particularly
notable. First, they show that while more
than half of the cells in the community are
active, 17% of cells are Pi+ and 27% are
DiBAC+, indicating a sizable minority of
damaged cells. By combining FACS with
16S rRNA sequencing, they could show
that the active and damaged subsets are
both dominated by members of the Firmi-
cutes order Clostridiales, although dif-
ferent genera dominate the active and
damaged subpopulations. These results
imply a key functional difference between
Firmicutes and the other major gut
phylum, Bacteroidetes: different subsets
of the Firmicutes are more likely to be
metabolically active and dying, indicating
a greater level of cell turnover among
them than the Bacteroidetes. They also
suggest the tantalizing finding that, in the
authors’ words, ‘‘members of the gut
microbiota may inhabit distinct ecological
niches, defined not only by physical loca-
tion and resource utilization but also by
their level of metabolic activity.’’
Second, antibiotics have a direct and
rapid physiological effect on the gut
microbiota. Notably, the Pi+ subset
doubled from 12% to 23%, and the
DiBAC+ subpopulation increased from
33% to 44%. This finding, which had
been suspected but not demonstrated,
shows the uneven manner in which antibi-
otic treatment affects cells in the popula-
tion over time. A panel of six host-targeted
drugs did not increase the proportion
of Pi+ and DiBAC+ cells, showing that
this effect is specific to compounds thatFebruary 13, 2013 ª2013 Elsevier Inc. 119
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Figure 1. An Evolution from Low- to High-Throughput Microbial
Community Profiling Techniques
The low-throughput technique of culture-based enumeration has given way to
deep sequencing, which enables a more thorough view of community compo-
sition. Turnbaugh and coworkers introduce a high-throughput technique,
based on FACS, that enables microbiota metabolic function to be profiled
en masse.
Cell Host & Microbe
Previewstarget bacteria. Surprisingly,
the proportion of HNA cells
is not significantly affected
by antibiotic treatment,
indicating that even broad-
spectrum antibiotics do not
have an immediate effect
on a substantial portion of
actively dividing bacteria:
more than half of the
population.
For the third notable
finding, Turnbaugh and co-
workers turned from their
FACS-based analysis of
metabolic activity to meta-
transcriptomics, a commu-
nity-wide profiling technique
with more precedent. They
show that treatment with anti-
biotics and other xenobiotics
increases the expression of
genes involved in drug resis-
tance and metabolism; for
example, multiple antibioticsincreased the expression of drug trans-
porters, while the histamine H2-receptor
antagonist nizatidine induced the expres-
sion of genes that might be involved in the
reduction of its terminal nitro group.
Three important questions remain.
First, how general are the findings? If
nearly all unperturbed gut communi-
ties—independent of composition—
show similar proportions of HNA and
damaged cells, then Turnbaugh and
coworkers’ results will be a true mile-
stone, but their technique will be of limited
use in assaying functional differences
among communities. In contrast, if
communities differ dramatically in their
proportions of HNA and damaged cells,
then this technique could be of broad
utility for distinguishing among function-
ally distinct communities.
Second, can the proportion of active
and damaged cells be linked to an impor-120 Cell Host & Microbe 13, February 13, 201tant phenotype or disease? FACS-seqwill
prove to be especially useful, both as
a diagnostic and as a tool to study
the molecular underpinnings of disease
etiology, if a microbiome-related disorder
is characterized by differences in commu-
nity metabolic activity. Importantly, the
authors show that xenobiotic-perturbed
communities exhibit interindividual and
temporal differences in their active and
damaged subsets, so it is likely that signif-
icant differences will be seen in any
disease state that results in a similar
perturbation (e.g., the oxidative stress of
inflammation).
Third, can the authors’ approach
be extended to other high-throughput,
community-wide measurements of func-
tion? Fluorophore-labeled metabolites
might allow the metabolism of a specific
dietary molecule to be read out, while
anaerobic fluorescent proteins could3 ª2013 Elsevier Inc.enable reporter assays of
signal transduction or meta-
bolic gene function. However
this new field unfolds, one
thing is certain: dyeing is just
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